More Women Needed in Biopharmaceutical Sector, Says Biocon Founder

More Women Needed in Biopharmaceutical Sector, Says Biocon Founder

Assessment

Interactive Video

Business, Health Sciences, Social Studies, Biology

University

Hard

Created by

Quizizz Content

FREE Resource

The video discusses the gender disparity in leadership roles within the pharmaceutical industry, highlighting the need for more women in top positions. It suggests focusing on potential rather than just performance to promote women leaders. The discussion also covers the impact of the pandemic on the pharmaceutical industry, particularly in India, and the challenges of vaccine distribution, emphasizing the importance of equitable access to vaccines for all countries.

Read more

7 questions

Show all answers

1.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What percentage of the workforce in the pharmaceutical industry is made up of women?

65%

75%

55%

45%

2.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is one of the main challenges women face in advancing to leadership roles in the pharmaceutical industry?

Insufficient experience

Gender bias

Lack of education

Limited networking opportunities

3.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What approach is suggested to increase the number of women in leadership roles?

Focus on potential

Focus on experience

Focus on education

Focus on age

4.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

In which sectors are women increasingly becoming founders and cofounders?

Finance and banking

Biotech and startups

Retail and fashion

Education and healthcare

5.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Who is one of the few women to have broken into the top leadership of big pharma companies?

Indra Nooyi

Mary Barra

Linda Johnson

Emma Walmsley

6.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is a major concern regarding vaccine distribution during the COVID-19 pandemic?

Vaccine nationalism

Vaccine storage

Vaccine cost

Vaccine safety

7.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Which vaccines are expected to be more accessible to lower and middle-income countries?

Covaxin and Covovax

Sputnik V and Sinovac

AstraZeneca and J&J

Moderna and Pfizer